Literature DB >> 1860620

Immunomodulating activity of heparin.

A Górski1, M Wasik, M Nowaczyk, G Korczak-Kowalska.   

Abstract

Aside from its well-known anticoagulant action, heparin has many other biologic effects. Recent data emphasize the immunomodulatory effects of low dose heparin. The agent alters the traffic of lymphocytes blocking their expression of heparanase, an enzyme that digests the extracellular matrix allowing cell penetration to target tissues. It also has a weak direct immunosuppressive action in vitro and in vivo. Oral administration of heparin may cause immunosuppression, although the effects are weaker than after subcutaneous administration.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1860620     DOI: 10.1096/fasebj.5.9.1860620

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  13 in total

1.  Neutrophil extracellular traps (NETs) contribute to pathological changes of ocular graft-vs.-host disease (oGVHD) dry eye: Implications for novel biomarkers and therapeutic strategies.

Authors:  Seungwon An; Ilangovan Raju; Bayasgalan Surenkhuu; Ji-Eun Kwon; Shilpa Gulati; Muge Karaman; Anubhav Pradeep; Satyabrata Sinha; Christine Mun; Sandeep Jain
Journal:  Ocul Surf       Date:  2019-04-06       Impact factor: 5.033

2.  Mast cell types in the lymph nodes of the opossum Didelphis albiventris (Marsupialia, Didelphidae).

Authors:  H Chiarini-Garcia; C R Machado
Journal:  Cell Tissue Res       Date:  1992-06       Impact factor: 5.249

3.  The effects of heparin and related molecules on vascular permeability and neutrophil accumulation in rabbit skin.

Authors:  Helen Jones; William Paul; Clive P Page
Journal:  Br J Pharmacol       Date:  2002-01       Impact factor: 8.739

4.  Pig-to-baboon heterotopic heart transplantation--exploratory preliminary experience with pigs transgenic for human thrombomodulin and comparison of three costimulation blockade-based regimens.

Authors:  Hayato Iwase; Burcin Ekser; Vikas Satyananda; Jay Bhama; Hidetaka Hara; Mohamed Ezzelarab; Edwin Klein; Robert Wagner; Cassandra Long; Jnanesh Thacker; Jiang Li; Hao Zhou; Maolin Jiang; Santosh Nagaraju; Huidong Zhou; Massimiliano Veroux; Pietro Bajona; Martin Wijkstrom; Yi Wang; Carol Phelps; Nikolai Klymiuk; Eckhard Wolf; David Ayares; David K C Cooper
Journal:  Xenotransplantation       Date:  2015-04-03       Impact factor: 3.907

5.  Characterization of a multilayer heparin coating for biomolecule presentation to human mesenchymal stem cell spheroids.

Authors:  J Lei; L T McLane; J E Curtis; J S Temenoff
Journal:  Biomater Sci       Date:  2014-05-01       Impact factor: 6.843

Review 6.  Engineering the Surface of Therapeutic "Living" Cells.

Authors:  Jooyeon Park; Brenda Andrade; Yongbeom Seo; Myung-Joo Kim; Steven C Zimmerman; Hyunjoon Kong
Journal:  Chem Rev       Date:  2018-01-16       Impact factor: 60.622

7.  Heparin affects the induction of regulatory T cells independent of anti-coagulant activity and suppresses allogeneic immune responses.

Authors:  Y Kashiwakura; H Kojima; Y Kanno; M Hashiguchi; T Kobata
Journal:  Clin Exp Immunol       Date:  2020-07-15       Impact factor: 4.330

Review 8.  Proteoglycans: the "Teflon" of the airways?

Authors:  C P Page
Journal:  Thorax       Date:  1997-10       Impact factor: 9.139

9.  Stimulation of Fas agonistic antibody-mediated apoptosis by heparin-like agents suppresses Hsp27 but not Bcl-2 protective activity.

Authors:  Florence Manero; Vesna Ljubic-Thibal; Maryline Moulin; Nadège Goutagny; Jean-Claude Yvin; André-Patrick Arrigo
Journal:  Cell Stress Chaperones       Date:  2004       Impact factor: 3.667

10.  Pharmacokinetics, toxicity, and activity of intravenous dextran sulfate in human immunodeficiency virus infection.

Authors:  C Flexner; P A Barditch-Crovo; D M Kornhauser; H Farzadegan; L J Nerhood; R E Chaisson; K M Bell; K J Lorentsen; C W Hendrix; B G Petty
Journal:  Antimicrob Agents Chemother       Date:  1991-12       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.